Dean M. Wingerchuk
Active 1997–2024
- 88
- Papers
- 31,213
- Citations
- 66
- h-index
- 88
- i10-index
Citations
Citation sources
Countries
Institutions
Fields
- Medicine84.3%
- Neuroscience5%
- Biochemistry, Genetics and Molecular Biology4.9%
- Immunology and Microbiology4.8%
- Engineering0.3%
- Materials Science0.2%
- Other0.5%
Topics
- Multiple Sclerosis Research Studies23.4%
- Peripheral Neuropathies and Disorders13.5%
- Systemic Lupus Erythematosus Research4.5%
- Autoimmune Neurological Disorders and Treatments4.1%
- Neuroinflammation and Neurodegeneration Mechanisms2.9%
- Ocular Diseases and Behçet’s Syndrome1.8%
- Other49.8%
Coauthors
- Brian G. Weinshenker51
- Sean J. Pittock45
- Claudia F. Lucchinetti28
- Vanda A. Lennon26
- Kazuo Fujihara18
- Andrew McKeon15
- Eoin P. Flanagan13
- Jeffrey L. Bennett13
- Michael Levy12
- Friedemann Paul11
- Ho Jin Kim10
- Ichiro Nakashima9
- Jacqueline Palace9
- John J. Chen9
- Orhan Aktaş9
- Romain Marignier9
- Anu Jacob8
- Bruce Cree8
- James P. Fryer8
- Marcelo Matiello8
- Daniel Cimbora7
- Dewei She7
- Eliezer Katz7
- Gary Cutter7
All papers
- International consensus diagnostic criteria for neuromyelitis optica spectrum disorders
Authors: Dean M. Wingerchuk, Brenda Banwell, Jeffrey L. Bennett, Philippe Cabre, William M. Carroll, Tanuja Chitnis, de Sèze, Kazuo Fujihara, Benjamin Greenberg, Anu Jacob, Sven Jarius, Marco Aurélio Lana–Peixoto, Michael Levy, Jack H. Simon, Silvia Tenembaum, Anthony Traboulsee, Patrick Waters, Kay E. Wellik, Brian G. Weinshenker - Neurology 2015 cited by 4,543
- Inebilizumab for the treatment of neuromyelitis optica spectrum disorder (N-MOmentum): a double-blind, randomised placebo-controlled phase 2/3 trial
Authors: Bruce Cree, Jeffrey L. Bennett, Ho Jin Kim, Brian G. Weinshenker, Sean J Pittock, Dean M. Wingerchuk, Kazuo Fujihara, Friedemann Paul, Gary Cutter, Romain Marignier, Ari Green, Orhan Aktaş, Hans‐Peter Hartung, Fred Lublin, Jörn Drappa, Gerard Barron, Soraya Madani, John N. Ratchford, Dewei She, Daniel Cimbora, Eliezer Katz - The Lancet 2019 cited by 717
- Eculizumab in Aquaporin-4–Positive Neuromyelitis Optica Spectrum Disorder
Authors: Sean J. Pittock, Achim Berthele, Kazuo Fujihara, Ho Jin Kim, Michael Levy, Jacqueline Palace, Ichiro Nakashima, Murat Terzi, N. А. Totolyan, Shanthi Viswanathan, Kaichen Wang, Amy Pace, Kenji P. Fujita, Róisín Armstrong, Dean M. Wingerchuk - New England Journal of Medicine 2019 cited by 846
- A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis
Authors: Vanda A. Lennon, Dean M. Wingerchuk, Thomas J. Kryzer, Sean J. Pittock, Claudia F. Lucchinetti, Kazuo Fujihara, Ichiro Nakashima, Brian G. Weinshenker - The Lancet 2004 cited by 3,227
- Epidemiology of Neuromyelitis Optica Spectrum Disorder and Its Prevalence and Incidence Worldwide
Authors: Jyh Yung Hor, Nasrin Asgari, Ichiro Nakashima, Simon Broadley, Maria Isabel Leite, Najib Kissani, Anu Jacob, Romain Marignier, Brian G. Weinshenker, Friedemann Paul, Sean J. Pittock, Jacqueline Palace, Dean M. Wingerchuk, Jacinta M. Behne, Michael R. Yeaman, Kazuo Fujihara - Frontiers in Neurology 2020 cited by 398
- The spectrum of neuromyelitis optica
Authors: Dean M. Wingerchuk, Vanda A. Lennon, Claudia F. Lucchinetti, Sean J. Pittock, Brian G. Weinshenker - The Lancet Neurology 2007 cited by 2,177
- Neuromyelitis Optica Spectrum Disorder
Authors: Dean M. Wingerchuk, Claudia F. Lucchinetti - New England Journal of Medicine 2022 cited by 196
- The contemporary spectrum of multiple sclerosis misdiagnosis
Authors: Andrew Solomon, Dennis Bourdette, Anne H. Cross, Angela Applebee, Philip Skidd, Diantha B. Howard, Rebecca Spain, Michelle Cameron, Edward Kim, Michele Mass, Vijayshree Yadav, Ruth H. Whitham, Erin E. Longbrake, Robert T. Naismith, Gregory F. Wu, Becky Parks, Dean M. Wingerchuk, Brian Rabin, Michel Toledano, W. Oliver Tobin, Orhun H. Kantarci, Jonathan L. Carter, B. Mark Keegan, Brian G. Weinshenker - Neurology 2016 cited by 324
- Association of MOG-IgG Serostatus With Relapse After Acute Disseminated Encephalomyelitis and Proposed Diagnostic Criteria for MOG-IgG–Associated Disorders
Authors: A. Sebastian López‐Chiriboga, Masoud Majed, James P. Fryer, Divyanshu Dubey, Andrew McKeon, Eoin P. Flanagan, Jiraporn Jitprapaikulsan, Naga Pradyumna Kothapalli, Jan‐Mendelt Tillema, John J. Chen, Brian G. Weinshenker, Dean M. Wingerchuk, Jessica Sagen, Avi Gadoth, Vanda A. Lennon, B. Mark Keegan, Claudia F. Lucchinetti, Sean J. Pittock - JAMA Neurology 2018 cited by 407
- Myelin Oligodendrocyte Glycoprotein Antibody–Positive Optic Neuritis: Clinical Characteristics, Radiologic Clues, and Outcome
Authors: John J. Chen, Eoin P. Flanagan, Jiraporn Jitprapaikulsan, A. Sebastian López‐Chiriboga, James P. Fryer, Jacqueline A. Leavitt, Brian G. Weinshenker, Andrew McKeon, Jan‐Mendelt Tillema, Vanda A. Lennon, W. Oliver Tobin, B. Mark Keegan, Claudia F. Lucchinetti, Orhun H. Kantarci, Collin M. McClelland, Michael S. Lee, Jeffrey L. Bennett, Victoria S. Pelak, Yanjun Chen, Gregory VanStavern, Ore-ofe O. Adesina, Eric Eggenberger, Marie D Acierno, Dean M. Wingerchuk, Paul W. Brazis, Jessica Sagen, Sean J. Pittock - American Journal of Ophthalmology 2018 cited by 400
- The clinical course of neuromyelitis optica (Devic’s syndrome)
Authors: Dean M. Wingerchuk, William F. Hogancamp, Peter C. O’Brien, Brian G. Weinshenker - Neurology 1999 cited by 1,815
- Multiple Sclerosis: Current and Emerging Disease-Modifying Therapies and Treatment Strategies
Authors: Dean M. Wingerchuk, Jonathan L. Carter - Mayo Clinic Proceedings 2014 cited by 414
- Epidemiology of aquaporin‐4 autoimmunity and neuromyelitis optica spectrum
Authors: Eoin P. Flanagan, Philippe Cabre, Brian G. Weinshenker, Jennifer L. St. Sauver, Debra J. Jacobson, Masoud Majed, Vanda A. Lennon, Claudia F. Lucchinetti, Andrew McKeon, Marcelo Matiello, Nilifur Kale, Dean M. Wingerchuk, Jay Mandrekar, Jessica Sagen, James P. Fryer, Angala Borders Robinson, Sean J. Pittock - Annals of Neurology 2016 cited by 339
- Treatment of MOG antibody associated disorders: results of an international survey.
Authors: Daniel Whittam, Venkatraman Karthikeayan, Emily Gibbons, Rachel Kneen, Saleel Chandratre, Olga Ciccarelli, Yael Hacohen, J. de Sèze, Kumaran Deiva, Rogier Q. Hintzen, Brigitte Wildemann, Sven Jarius, Ingo Kleiter, Kevin Rostásy, Peter Huppke, B Hemmer, Friedemann Paul, Orhan Aktaş, Anne‐Katrin Pröbstel, Georgina Arrambide, Mar Tintoré, Maria Pia Amato, Margherita Nosadini, Maria Margherita Mancardi, Marco Capobianco, Zsolt Illés, Aksel Sıva, Ayşe Altıntaş, G. Akman‐Demir, Lekha Pandit, M. Apiwattankul, Jyh Yung Hor, S Viswanathan, Wei Qiu, Han Jo Kim, Ichiro Nakashima, Kazuo Fujihara, Sudarshini Ramanathan, Russell C. Dale, M. Boggild, Simon Broadley, M. A. Lana-Peixoto, Douglas Kazutoshi Sato, Sílvia Tenembaum, P. Cabré, Dean M. Wingerchuk, Brian G. Weinshenker, Benjamin Greenberg, Marcelo Matiello, Eric C. Klawiter, Jeffrey L. Bennett, Asya I. Wallach, Ilya Kister, Brenda Banwell, Anthony Traboulsee, Daniela Pohl, Jacqueline Palace, Maria Isabel Leite, Michael Levy, Romain Marignier, Tom Solomon, Ming Lim, Saif Huda, A. Jacob - 2020 cited by 138
- Steroid-sparing maintenance immunotherapy for MOG-IgG associated disorder
Authors: John J. Chen, Eoin P. Flanagan, M. Tariq Bhatti, Jiraporn Jitprapaikulsan, Divyanshu Dubey, A. Sebastian López‐Chiriboga, James P. Fryer, Brian G. Weinshenker, Andrew McKeon, Jan‐Mendelt Tillema, Vanda A. Lennon, Claudia F. Lucchinetti, Amy Kunchok, Collin M. McClelland, Michael S. Lee, Jeffrey L. Bennett, Victoria S. Pelak, Gregory Van Stavern, Ore-ofe O. Adesina, Eric Eggenberger, Marie D Acierno, Dean M. Wingerchuk, Byron L. Lam, Heather E. Moss, Shannon Beres, Aubrey L. Gilbert, Veeral Shah, Grayson W. Armstrong, Gena Heidary, Dean M. Cestari, Hadas Stiebel‐Kalish, Sean J. Pittock - Neurology 2020 cited by 231
- Serum neurofilament light chain levels at attack predict post-attack disability worsening and are mitigated by inebilizumab: analysis of four potential biomarkers in neuromyelitis optica spectrum disorder
Authors: Orhan Aktaş, Hans‐Peter Hartung, Michael Smith, William A. Rees, Kazuo Fujihara, Friedemann Paul, Romain Marignier, Jeffrey L. Bennett, Ho Jin Kim, Brian G. Weinshenker, Sean J. Pittock, Dean M. Wingerchuk, Gary Cutter, Dewei She, Michele Gunsior, Daniel Cimbora, Eliezer Katz, Bruce Cree - Journal of Neurology Neurosurgery & Psychiatry 2023 cited by 45
- Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis
Authors: Shanu F. Roemer, Joseph E. Parisi, Vanda A. Lennon, Eduardo E. Benarroch, Hans Lassmann, Wolfgang Brück, Raúl N. Mandler, B. G. Weinshenker, S J Pittock, Dean M. Wingerchuk, Claudia F. Lucchinetti - Brain 2007 cited by 714
- Cerebral enhancement in MOG antibody-associated disease
Authors: Paul Elsbernd, Laura Cacciaguerra, Karl N. Krecke, John J. Chen, David Gritsch, A. Sebastian López‐Chiriboga, Elia Sechi, Vyanka Redenbaugh, Padraig P. Morris, Jonathan L Carter, Dean M. Wingerchuk, Jan‐Mendelt Tillema, Cristina Valencia-Sánchez, Smathorn Thakolwiboon, Sean J. Pittock, Eoin P. Flanagan - Journal of Neurology Neurosurgery & Psychiatry 2023 cited by 31
- Estriol combined with glatiramer acetate for women with relapsing-remitting multiple sclerosis: a randomised, placebo-controlled, phase 2 trial
Authors: Rhonda R. Voskuhl, He-Jing Wang, Tao Wu, Nancy L. Sicotte, Kunio Nakamura, Florian Kurth, Noriko Itoh, Jenny Bardens, Jacqueline Bernard, John R. Corboy, Anne H. Cross, Suhayl Dhib‐Jalbut, Corey C. Ford, Elliot M. Frohman, Barbara S. Giesser, Dina Jacobs, Lloyd H. Kasper, Sharon Lynch, Gareth Parry, Michael K. Racke, Anthony T. Reder, John Rose, Dean M. Wingerchuk, Allan MacKenzie‐Graham, Douglas L. Arnold, Chi Hong Tseng, Robert M. Elashoff - The Lancet Neurology 2015 cited by 201
- Long‐Term Safety and Efficacy of Eculizumab in Aquaporin‐4 IgG‐Positive NMOSD
Authors: Dean M. Wingerchuk, Kazuo Fujihara, Jacqueline Palace, Achim Berthele, Michael Levy, Jung Bin Kim, Ichiro Nakashima, Celia Oreja‐Guevara, Kai‐Chen Wang, Larisa Miller, Shulian Shang, Guido Sabatella, Marcus Yountz, Sean J. Pittock, PREVENT Study Group - Annals of Neurology 2021 cited by 96
- Neuromyelitis Optica Brain Lesions Localized at Sites of High Aquaporin 4 Expression
Authors: Sean J. Pittock, Brian G. Weinshenker, Claudia F. Lucchinetti, Dean M. Wingerchuk, John R. Corboy, Vanda A. Lennon - Archives of Neurology 2006 cited by 702
- Eculizumab monotherapy for NMOSD: Data from PREVENT and its open-label extension
Authors: Sean J. Pittock, Kazuo Fujihara, Jacqueline Palace, Achim Berthele, Ho Jin Kim, Celia Oreja‐Guevara, Ichiro Nakashima, Michael Levy, Shulian Shang, Marcus Yountz, Larisa Miller, Róisín Armstrong, Dean M. Wingerchuk, the PREVENT Study Group - Multiple Sclerosis Journal 2021 cited by 78
- Eculizumab in AQP4-IgG-positive relapsing neuromyelitis optica spectrum disorders: an open-label pilot study
Authors: Sean J. Pittock, Vanda A. Lennon, Andrew McKeon, Jay Mandrekar, Brian G. Weinshenker, Claudia F. Lucchinetti, Orna O’Toole, Dean M. Wingerchuk - The Lancet Neurology 2013 cited by 394
- Smoking: effects on multiple sclerosis susceptibility and disease progression
Authors: Dean M. Wingerchuk - Therapeutic Advances in Neurological Disorders 2011 cited by 187
